Karuna Therapeutics

Youtube Subscribe

Open: 317.29 Close: 316.75 Change: -0.54

You don't have time to read all about Karuna Therapeutics. An AI summarizes all the information for you.

Are looking for the most relevant information about Karuna Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Karuna Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Karuna Therapeutics are: Karuna, Therapeutics, Inc, Chief, Brannan, Sells, Shares, and the most common words in the summary are: karuna, therapeutic, stock, best, market, inc, krtx, . One of the sentences in the summary was: This latest transaction continues the trend of insider sales.. Other searches …

Concept Map

Semantic Network

Stock Summary

Karuna Therapeutics, Inc. creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate includes KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for.

Today's Summary

Chief Medical Officer Stephen Brannan Sells 15,000 Shares of Karuna Therapeutics Inc. Chief medical officer stephen brannan sells 15,00 shares of karuna therapeutics inc. This latest transaction continues the trend of insider sales.

Today's News

Chief Medical Officer Stephen Brannan Sells 15,000 Shares of Karuna Therapeutics Inc. Chief medical officer stephen brannan sells 15,00 shares of karuna therapeutics inc. This latest transaction continues the trend of insider sales. Kuehn Law is investigating whether the Boards of the below companies failed to disclose material information. Rowley Law PLLC is Investigating Proposed Acquisition of Karuna Therapeutics, Inc. Under the agreement, shareholders will be entitled to a payment of $330.00. Karuna Therapeutics, Inc. (NASDAQ:KRTX) insider stephen k. brannan sells 15,000 shares of stock - defense world. Brannan Sells 15,00 Shares of Stock Posted by Defense World Staff on Jan 10th, 2024.

Stock Profile

"Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate includes KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of various peripheral tissues and dementia-related psychosis, including Alzheimer's disease. The company also focuses on developing other muscarinic-targeted drug candidates; and intends to develop lead candidature TRPC4/5 and KAR-2618 for the treatment of mood and anxiety disorders. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts."

Keywords

This document will help you to evaluate Karuna Therapeutics without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Karuna Therapeutics are: Karuna, Therapeutics, Inc, Chief, Brannan, Sells, Shares, and the most common words in the summary are: karuna, therapeutic, stock, best, market, inc, krtx, . One of the sentences in the summary was: This latest transaction continues the trend of insider sales.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #karuna #therapeutic #stock #best #market #inc #krtx.

Read more →

Youtube Subscribe

---